Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07494968 · ClinicalTrials.gov registry record · NA
Defining Objective Markers of Compliance for Dietary Therapies in IBS
A NA study, sponsored by University of Michigan.
- Recruiting
- Registry status
- NA
- Development phase
- 94
- Enrollment target
NCT07494968: Recruiting NA study, sponsored by University of Michigan.
NCT07494968 is a NA study that is actively recruiting participants, run by University of Michigan. The registered enrollment target is 94 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07494968, a NA study, is actively recruiting participants, sponsored by University of Michigan.
- RECRUITING
- Registry status
- NA
- Development phase
- 94 participants
- Enrollment target
Study Summary
This research will investigate if a specific marker in your stool or urine can be used to track changes in your carbohydrate intake including fructo-oligosaccharide and mannitol intake
Primary Outcome
Assessed using 24-hour recall
Interventions
- BEHAVIORAL Diet A - elimination diet
- BEHAVIORAL Diet B - healthy eating diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 94 participants |
| Start Date | 2026-05-11 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07494968 shows while recruiting
NCT07494968 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 94 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 2 interventions - of which Diet A - elimination diet is the first listed.
NCT07494968 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07494968 about?
NCT07494968 is a clinical study titled "Defining Objective Markers of Compliance for Dietary Therapies in IBS". This research will investigate if a specific marker in your stool or urine can be used to track changes in your carbohydrate intake including fructo-oligosaccharide and mannitol intake
What is the current status of trial NCT07494968?
This trial is currently recruiting. It is a NA study. The enrollment target is 94 participants. The study started on 2026-05-11. Estimated completion is 2027-12.
What interventions are being tested in trial NCT07494968?
The interventions under investigation include: Diet A - elimination diet (BEHAVIORAL), Diet B - healthy eating diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT07494968?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07494968's enrollment target sits among peer trials
94 935th of 2000 higher than 1,064 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03747146 · 94 participants · NA
Enhanced Recovery After Surgery (ERAS) Total Knee Replacement (TKR) With a Transitional Pain Service
- NCT04061421 · 94 participants · Phase 1
Active Myeloid Target Compound Combinations in MDS/MPN Overlap Syndromes Overlap Syndromes (ABNL-MARRO)
- NCT04205968 · 94 participants · Phase 2
Ramucirumab and Paclitaxel or FOLFIRI in Advanced Small Bowel Cancers
- NCT04464759 · 94 participants · Phase 1
A Study of Nivolumab and Hydroxychloroquine or Nivolumab/Ipilimumab and Hydroxychloroquine in Advanced Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI